Relmada Therapeutics Inc (RLMD)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -38.7M | -28.15M | -26.03M | -22.69M | -26.83M | -22.99M | -18.82M | -23.01M |
Pre Tax Income | -37.95M | -26.32M | -25.3M | -22M | -25.17M | -21.83M | -17.77M | -21.73M |
Net Income | -37.95M | -26.32M | -25.3M | -22M | -25.17M | -21.83M | -17.77M | -21.73M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -32.35M | -28.15M | -26.03M | -22.69M | -26.83M | -22.99M | -18.82M | -23.01M |
EBITDA | -38.7M | -28.15M | -26.03M | -22.69M | -26.83M | -22.99M | -18.82M | -23.01M |
Year End December 30 2023 | 2017 | 2018 | 2019 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -7.22M | -6.92M | -12.73M | -8.27M | -60.84M | -125.7M | -161.25M | -103.7M |
Pre Tax Income | -6.29M | -8.96M | -17.32M | -8.2M | -59.46M | -125.75M | -157.04M | -98.79M |
Net Income | -6.29M | -8.96M | -17.32M | -8.2M | -59.46M | -125.75M | -157.04M | -98.79M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.502 | -0.714 | -0.444 | -0.567 | -3.64 | -4.533 | -5.218 | -3.282 |
EBIT | -7M | -6.92M | -16.5M | -8.27M | -60.84M | -125.7M | -154.9M | -103.7M |
EBITDA | -7.22M | -6.92M | -12.73M | -8.27M | -60.84M | -125.7M | -161.25M | -103.7M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.